SBI Securities
MIRM icon

SBI Securities’s Mirum Pharmaceuticals MIRM Stock Holding History

SBI Securities’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.7K Buy
+160
New +$16.7K ﹤0.01% 1712
2026
Q2 		– Sell
-20
Closed -$1.85K – 4154
2026
Q1 		$1.85K Buy
+20
New +$1.88K ﹤0.01% 2448
2025
Q4 		– Sell
-150
Closed -$11K – 4146
2025
Q3 		$11K Buy
150
+121
+417% +$7.69K ﹤0.01% 1731
2025
Q2 		$1.48K Buy
+29
New +$1.29K ﹤0.01% 2518

Other funds holding MIRM

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Contravisory Investment Management
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
WIA
Wetzel Investment Advisors Indianapolis, Indiana $290M AUM 16.64% 1-Year Est. Return

SBI Securities's MIRM Position: Q3 2026 in Review

SBI Securities opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2026: 160 shares worth $13.7K. The stake represents ﹤0.01% of the portfolio and ranks #1712 among its holdings. This is a return to the name: SBI Securities previously reported a position in MIRM as recently as Q1 2026.

SBI Securities first reported a position in MIRM in Q2 2025 and has held it in 4 quarters since. 30 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • SBI Securities held 160 shares of Mirum Pharmaceuticals worth $13.7K as of Q3 2026.
  • Mirum Pharmaceuticals was a new SBI Securities position in Q3 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #1712 holding.
  • SBI Securities first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 30 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.